Project Details
Description
Phase II. Randomized, Double-Blind Study to Assess the Efficacy and Safety of Lebrikzumab in Patients with Idiopathic Pulmonary Fibrosis
| Status | Finished |
|---|---|
| Effective start/end date | 6/25/14 → 12/31/17 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.